News related to Cipro I.V. (Ciprofloxacin) and/or conditions it is approved for
Aradigm Doses First Patient In Long-Term Phase 2 Study Of A Novel Inhaled Ciprofloxacin Formulation For The Management Of Respiratory Infections
Source: Respiratory / Asthma News From Medical News Today [2009.11.18]
Aradigm Corporation (OTCBB:ARDM) (the "Company") announced that the first patient was dosed in a 6-month, multicenter, international Phase 2 clinical trial of a novel version of inhaled ciprofloxacin (ARD-3150) in 40 adult patients with non-cystic fibrosis bronchiectasis. The randomized, double-blind, placebo-controlled trial will be conducted in Australia and New Zealand.
ciprofloxacin/dexamethasone-otic suspension, Ciprodex
Source: MedicineNet Ear Tubes Specialty [2005.03.02]
Title: ciprofloxacin/dexamethasone-otic suspension, Ciprodex
Category: Medications
Created: 3/2/2005
Last Editorial Review: 3/2/2005
|
